表紙
市場調查報告書
商品編碼
269628

數位病理學系統的全球市場

Digital Pathology Systems

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 620 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球數位病理學系統市場相關調查,彙整市場趨勢與產品概要,各地區趨勢,及打入市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 免疫化學:概要
    • 研究抗體市場
    • 購買決策影響因素
    • 美國壟斷全球免疫化學市場
    • 新興市場潛力巨大
    • 目錄抗體:最大市場區隔
    • 自訂抗體
    • 一級塗料抗體壟斷市場
    • 競爭模式數位病理學系統:準確度,效率分析,降低成本
    • 促進工作流程的效率和降低成本的需求
    • 已開發國家壟斷
    • 新興國家的急速成長 其他
  • 競爭環境
    • 競爭市場
    • Leica壟斷市場
    • Philips的IntelliSite病理學系統:先進的數位病理學系統
  • 推動市場的要素,趨勢,課題
  • 產品概要
    • 病理學的簡介
    • 數位病理學:電腦實現的病理學流程
    • 零組件
  • 產品引進/技術創新
  • 近幾年的產業活動
  • 全球市場參與企業
    • 3DHISTECH Ltd.
    • Apollo Enterprise Imaging Corp.
    • Carl Zeiss AG
    • Corista LLC
    • Definiens AG
    • HAMAMATSU PHOTONICS
    • Huron Digital Pathology, Inc.
    • Leica Biosystems Nussloch GmbH
    • MikroScan Technologies, Inc.
    • Olympus Corporation
    • Philips Healthcare
    • Pixcelldata Ltd.
    • Ventana Medical Systems, Inc.
    • VMscope GmbH
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國
目錄
Product Code: MCP-6740

Abstract:

Global Digital Pathology Systems Market to Reach US$1.4 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Digital Pathology Systems estimated at US$573.9 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 13.9% over the analysis period 2020-2027.Device, one of the segments analyzed in the report, is projected to grow at a 13.8% CAGR to reach US$753.1 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 14.6% CAGR for the next 7-year period. This segment currently accounts for a 29.2% share of the global Digital Pathology Systems market.

The U.S. Accounts for Over 42.1% of Global Market Size in 2020, While China is Forecast to Grow at a 15.1% CAGR for the Period of 2020-2027

The Digital Pathology Systems market in the U.S. is estimated at US$241.7 Million in the year 2020. The country currently accounts for a 42.12% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$114.2 Million in the year 2027 trailing a CAGR of 15.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 12.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$114.2 Million by the year 2027.

Other Segments Segment Corners a 17.8% Share in 2020

In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 12.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$86.6 Million in the year 2020 will reach a projected size of US$200.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.5 Million by the year 2027, while Latin America will expand at a 12.5% CAGR through the analysis period.

Select Competitors (Total 74 Featured) -

  • 3DHISTECH Ltd.
  • Apollo Enterprise Imaging Corp.
  • Carl Zeiss AG
  • Corista LLC
  • Glencoe Software, Inc
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology, Inc.
  • Indica Labs
  • Inspirata Inc
  • KANTERON SYSTEMS S.L.U
  • KONFOONG BIOTECH INTERNATIONAL CO.,LTD
  • Leica Biosystems Nussloch GmbH
  • MikroScan Technologies
  • Inc.
  • Objective Pathology Services
  • Olympus Corporation
  • OptraSCAN, Inc
  • Philips Healthcare
  • Proscia Inc
  • Sectra AB
  • Visiopharm A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
    • EXHIBIT 1: Global Venture Capital Investments in Digital Health Startups (In US$ Billion)
    • EXHIBIT 2: % Share VC Investments by Category for 2020
    • FDA Temporarily Relaxes Guidelines to Promote Remote Digital Pathology Services amid COVID-19 Pandemic
    • COVID-19 Highlights Need to Implement Structured Online Curriculum for Pathology Training
    • Future Outlook of Pathology Post-COVID-19
    • Digital Pathology: An Introduction
    • Key Digital Pathology Tools
    • Market Outlook
    • US and Europe Maintain Dominance
    • Emerging Markets to Experience Strong Growth
    • Scanners Lead Digital Pathology Market
    • Software Segment Post Strong Growth
    • Disease Diagnosis: Major Application of Digital Pathology Systems
    • Telepathology Experiences Strong Growth
    • Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
    • EXHIBIT 3: Global Digital Pathology Systems Market by End-Use: 2020
    • Major Issues Hampering Adoption of Digital Pathology Systems
    • Competitive Landscape
    • EXHIBIT 4: Market Share of Leading Players in Digital Pathology Systems Market: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Advancements Drive Adoption of Digital Pathology Systems
    • Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
    • EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
    • Advantages of AI-Powered Digital Pathology
    • Digital Pathology Benefits Drug Discovery Process
    • Need for Early Diagnosis Puts Focus on Digital Pathology
    • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
    • EXHIBIT 5: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 6: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • EXHIBIT 7: Global New Cancer Cases and Cancer-related Deaths by Cancer Site (in %) for 2018
    • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
    • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
    • Clinical Research Continues to be Core Vertical for Digital Pathology
    • Digital Imaging and Robotic Light Microscopy Boost Growth
    • Computational Pathology for Leading-Edge Image Analytics
    • Cloud Platform Gains Momentum
    • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
    • Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
    • EXHIBIT 8: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Increased Focus on Companion Diagnostics to Benefit Market Growth
    • Improving Healthcare & Research Expenditure to Support Growth
    • EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Aging Population: A Key Opportunity Indicator
    • EXHIBIT 10: Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
    • EXHIBIT 11: Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
    • EXHIBIT 12: Global Cancer Deaths by Age Group (in %) for 2019
    • Challenges Facing Digital Pathology Systems Market
    • High Costs
    • Workflow Integration with Other Related Functions
    • Other Issues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 3: World 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 6: World 12-Year Perspective for Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 9: World 12-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 12: World 12-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 15: World 12-Year Perspective for Human Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 18: World 12-Year Perspective for Veterinary Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 21: World 12-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 24: World 12-Year Perspective for Hospitals & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 27: World 12-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Triggers Demand for Digital Pathology
    • Market Overview
    • Increasing Pressure on Pathological Labs: Cornerstone for Growth
    • TABLE 28: USA Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 30: USA 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 33: USA 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 36: USA 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 39: Canada 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 42: Canada 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 45: Canada 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • JAPAN
    • Market Overview
    • TABLE 46: Japan Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 48: Japan 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 51: Japan 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 54: Japan 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • CHINA
    • Market Overview
    • TABLE 55: China Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 57: China 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 60: China 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 63: China 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • EUROPE
    • Market Overview
    • TABLE 64: Europe Current & Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 65: Europe Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 66: Europe 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 69: Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 72: Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 75: Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: France Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 78: France 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 81: France 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 84: France 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 87: Germany 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 90: Germany 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 93: Germany 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Italy Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 96: Italy 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 99: Italy 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 102: Italy 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 105: UK 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 108: UK 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 111: UK 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • SPAIN
    • TABLE 112: Spain Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Spain Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 114: Spain 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 117: Spain 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 118: Spain Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 120: Spain 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • RUSSIA
    • TABLE 121: Russia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Russia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 123: Russia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 126: Russia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 127: Russia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 129: Russia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ASIA-PACIFIC
    • Market Overview
    • TABLE 139: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • AUSTRALIA
    • TABLE 151: Australia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Australia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 153: Australia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 156: Australia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 157: Australia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 159: Australia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • INDIA
    • Market Overview
    • Inadequate Infrastructure Impedes Adoption of Telepathology
    • TABLE 160: India Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: India Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 162: India 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 165: India 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 166: India Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 168: India 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • SOUTH KOREA
    • TABLE 169: South Korea Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: South Korea Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 171: South Korea 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 174: South Korea 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 177: South Korea 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 180: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • LATIN AMERICA
    • TABLE 187: Latin America Current & Future Analysis for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 188: Latin America Historic Review for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 189: Latin America 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 192: Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 195: Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 198: Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ARGENTINA
    • TABLE 199: Argentina Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Argentina Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 201: Argentina 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 204: Argentina 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 207: Argentina 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • BRAZIL
    • TABLE 208: Brazil Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Brazil Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 210: Brazil 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 213: Brazil 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 216: Brazil 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • MEXICO
    • TABLE 217: Mexico Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Mexico Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 219: Mexico 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 222: Mexico 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 225: Mexico 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 226: Rest of Latin America Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Rest of Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 228: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • MIDDLE EAST
    • TABLE 235: Middle East Current & Future Analysis for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 236: Middle East Historic Review for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 237: Middle East 12-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 240: Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 243: Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 246: Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • IRAN
    • TABLE 247: Iran Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Iran Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 249: Iran 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Iran Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 252: Iran 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 253: Iran Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 255: Iran 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • ISRAEL
    • TABLE 256: Israel Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Israel Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 258: Israel 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Israel Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 261: Israel 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 262: Israel Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 264: Israel 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 265: Saudi Arabia Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Saudi Arabia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 267: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Saudi Arabia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 270: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 274: UAE Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: UAE Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 276: UAE 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: UAE Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 279: UAE 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 280: UAE Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 282: UAE 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 283: Rest of Middle East Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: Rest of Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 285: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Rest of Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 288: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027
  • AFRICA
    • TABLE 292: Africa Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Africa Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 294: Africa 12-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Sales for Device, Software and Other Segments for the Years 2015, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Africa Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 297: Africa 12-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Sales for Human Pathology and Veterinary Pathology for the Years 2015, 2020 & 2027
    • TABLE 298: Africa Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019 and % CAGR
    • TABLE 300: Africa 12-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 74